Table:
begin	end	state
1	25	cytoplasmic
26	48	transmembrane
49	53	non-cytoplasmic
54	75	transmembrane
76	83	cytoplasmic
84	101	transmembrane
102	120	non-cytoplasmic
121	154	transmembrane
155	180	cytoplasmic
181	205	transmembrane
206	236	non-cytoplasmic
237	259	transmembrane
260	273	cytoplasmic
274	297	transmembrane
298	307	non-cytoplasmic
308	328	transmembrane
329	350	cytoplasmic
351	369	transmembrane
370	374	non-cytoplasmic
375	392	transmembrane
393	412	cytoplasmic
413	439	transmembrane
440	449	non-cytoplasmic
450	469	transmembrane
470	473	cytoplasmic
474	493	transmembrane
494	498	non-cytoplasmic
499	520	transmembrane
521	538	cytoplasmic
539	558	transmembrane
559	563	non-cytoplasmic
564	585	transmembrane
586	591	cytoplasmic
592	610	transmembrane
611	615	non-cytoplasmic
616	636	transmembrane
637	649	cytoplasmic

Input:
>WP_111608933.1 NCBI__GCF_003259225.1:WP_111608933.1
MLNSGSSNGFQSLLLESKFAGGKERLAVSLLFSVIAAGIAGLVLYGAYYGGITALLLRSA
FFSLVAAAAMLFYALRYKSVAGRGAFYLLTLLALIPGPYLWHNYIDIVMRGAMSIGQDRW
IFMALIAVVFVFVRIAVGRALIILMTLAFLYAYFGDAIPGKYGHSGYDLSRLTSTLMLST
EGVFGVPMGVAVEYIFLFGLFGAILTKIGTGEVFVDIARGVTGRVQGGPGLSAALSSALL
GSLNGSAVANVVTTGTFTIPLMKRVGYSAKLAGAIEAAASSAGQIMPPVMGAAAFLMAEM
IGIPYAEVALAALVPALLYIFALMIAVRLEAGRLNLARDTGAGLQLLLTTLKTKSYLLLP
LVVLIGLMISGKSPTQAAVMGILAGLAVCPWKKETRINMFDLISACKETLTSTLPIVAAV
AAAGVIIGVLNLTGMGLMLSGLIIELGDGNLWAVLLLTALASFVLGMGLPTSAAYLLLAV
LVAPAMTQLGMEALSAHMFIFYFGLVSAITPPVALAAYAAATISGADANETAVESMRLGF
VKLLVPFLFVTMPGVLLIGTTTSVIAAITFATLATASMSIGFSGWLREPLSWLTRLLYVV
AAVLIAWPAAATDTSIAVLGARIIGIVLFAGLLFKASIQTKPNTMKAEV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server